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The activity of imipenem against Pseudomonas aeruginosa HUS-3 decreased by 16 times in the presence of
substances eluted from siliconized latex urinary catheters (SLUCs). SLUCs did not inactivate imipenem or
increase b-lactamase activity. The outer membrane of P. aeruginosa HUS-3 grown in the presence of eluate
lacked an OprD-like protein and expressed a new 50-kDa protein. The decreased activity of imipenem against
P. aeruginosa in the presence of SLUCs is related to the loss of an OprD-like protein and the expression of a
new outer membrane protein.
Pseudomonas aeruginosa is an important cause of urinary
tract infection in patients with urinary catheters (17). The or-
ganism is able to colonize the surface of the catheter, forming
biofilms that interfere with the activity of antimicrobial agents
(14). It has been shown that P. aeruginosa adheres in vitro more
efficaciously to siliconized latex urinary catheters (SLUCs)
than to other plastic biomaterials (7–9). SLUCs elute sub-
stances that can be used by P. aeruginosa to grow (8) but are
toxic for Escherichia coli or human polymorphonuclear leuko-
cytes (7). It was reported previously that MICs of meropenem
(MPM) against P. aeruginosa increased by 8 to 16 times in the
presence of SLUC segments (15). It was postulated that the
decreased activity of MPM could be related to the elution of
substances from SLUCs but other mechanisms were also con-
sidered.
Resistance to imipenem (IMP) in P. aeruginosa has been
shown to be related to the loss of the outer membrane protein
OprD (23) coupled with the production of chromosomal b-
lactamase (6, 22). MPM is more active than IMP against this
microorganism, which could be related to its greater stability in
the presence of the chromosomal b-lactamase (22). More re-
cently, it has been reported that resistance of P. aeruginosa to
these and other agents could be also related to the elimination
of drugs by efflux systems (4, 12, 18–20).
This study was undertaken to evaluate the role of outer
membrane protein alterations and/or production of b-lactam-
ase in the decreased activity of IMP against P. aeruginosa in the
presence of eluates from SLUCs.
(This research was presented in part at the 37th Interscience
Conference on Antimicrobial Agents and Chemotherapy, To-
ronto, Canada, 28 September to 1 October 1997 [10].)
P. aeruginosa HUS-3 is a previously described clinical isolate
(15). P. aeruginosa PAO1 and an OprD mutant were kindly
provided by J. Trı́as (Microcide Pharmaceuticals Inc., Moun-
tain View, Calif.). IMP-resistant mutants from P. aeruginosa
HUS-3 were obtained on plates of Mueller-Hinton agar con-
taining 8 mg of IMP/ml. One of these mutants was retained and
was designated P. aeruginosa HUS-3/MUT2. Segments (eight
segments 0.5 cm in length/ml of media) of SLUCs (pediatric
siliconized latex Foley catheters; Euromedical, Kuala Lumpur,
Malaysia) were incubated in sterile cation-adjusted Mueller-Hin-
ton broth (MHB) at 37°C for 24 h. Catheter segments were
removed, and the resulting broth containing the substances
eluted from SLUCs (eluate) was used immediately. MICs of
IMP, ceftazidime, cefepime, cefpirome, trimethoprim, tetra-
cycline, and chloramphenicol were determined by a microdi-
lution assay according to National Committee for Clinical Lab-
oratory Standards guidelines (13) using both MHB and eluate
as media. Eluate diluted in MHB in different proportions (1:2,
1:4, 1:8, and 1:16) was also used to determine the activities of
IMP against P. aeruginosa HUS-3 and MUT2. To evaluate the
possible inactivation of IMP by eluate, IMP at a concentration
of 5,120 mg/ml was incubated at 37°C for 24 h in MHB and in
eluate. MICs of IMP, preincubated in either MHB or eluate,
for P. aeruginosa HUS-3 were determined in both MHB and
eluate and compared with MICs of freshly prepared IMP de-
termined in the same conditions. In another set of experi-
ments, P. aeruginosa HUS-3 was grown in MHB and in eluate.
The activity of IMP against bacteria grown in either medium
was again determined in MHB and in eluate. Outer membrane
proteins of P. aeruginosa HUS-3 grown in MHB or eluate were
prepared as previously described (4), separated by sodium do-
decyl sulfate-polyacrylamide gel electrophoresis using Laemm-
li’s buffers (5), and stained with Coomassie blue. b-Lactamase
activity was determined spectrophotometrically using the crude
supernatants obtained after sonication of P. aeruginosa grown
either in HMB or in eluate and cephaloridine as substrate. One
unit of activity was defined as the amount of enzyme that hy-
drolyzed 1 mmol of substrate per minute at 37°C at 295 nm.
In a previous report, we showed that SLUCs interfere in
vitro with the inhibitory activity of MPM against P. aeruginosa
(15). In the present report, it is shown that SLUCs also affect
the activity of IMP. It was previously postulated that SLUCs
are degraded when immersed in a liquid phase independently
of the presence of microorganisms and that the silicone layer
covering urinary catheters may dissolve in vivo, thus exposing
the inner latex layer to the environment, the latex being re-
sponsible for tissue toxicity (21). The results of this study sug-
gest that the eluate from SLUCs contains some substance(s)
which inhibits IMP activity against P. aeruginosa HUS-3. The
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activity of IMP against P. aeruginosa HUS-3 decreased by 16
times when it was measured in eluate from SLUCs (Table 1).
This effect progressively disappeared when the eluate was di-
luted in MHB. Eluate kept at 4°C for up to 4 weeks maintained
its activity against IMP (data not shown). MICs of IMP against
P. aeruginosa HUS-3 were 8, 4, 1, and 1 mg/ml when eluate was
diluted in MHB 1:2, 1:4, 1:8, and 1:16, respectively. MICs of
IMP against MUT2 were the same (32 mg/ml) in both MHB
and eluate (either pure or diluted 1:2 to 1:16 in MHB). Simi-
larly, the MIC of IMP against P. aeruginosa PAO1 was 8 to 16
times higher than the corresponding value against the organ-
ism grown in MHB, while against the OprD deficient mutant
both MICs were the same (16 mg/ml). Preincubation of IMP in
eluate did not result in inactivation of the drug as determined
by the bioassay with P. aeruginosa HUS-3. MICs of eluate-
preincubated IMP were 2 mg/ml in MHB and 32 mg/ml in
eluate, exactly the same values as obtained with IMP preincu-
bated in MHB, and only one dilution step higher than those
obtained with freshly prepared IMP. The MIC of IMP against
P. aeruginosa HUS-3 grown in eluate was 16 mg/ml when per-
formed in eluate and 1 mg/ml when performed in MHB; the
corresponding values, determined in a parallel experiment with
the organism grown in MHB were the same, as previously
observed.
P. aeruginosa HUS-3 grown in eluate lost an outer mem-
brane protein comigrating with OprD of P. aeruginosa PAO1
and expressed a new outer membrane protein of about 50 kDa
(Fig. 1). Mutant MUT2 did not express OprD in MHB and,
like its parental strain, expressed a new protein of ca. 50 kDa
when grown in eluate. The outer membrane protein profile of
P. aeruginosa PAO1 was similar to that of HUS-3, while that of
the PAO1 OprD-deficient mutant was similar to that of MUT2
(data not shown). The expression of new proteins of around 50
kDa in the outer membrane of P. aeruginosa has been recently
related to the expression of efflux systems (11). The pattern of
outer membrane proteins of P. aeruginosa HUS-3 grown in the
presence of eluate is similar to that of nfxC-type mutants (12).
Köhler et al. (4) have recently reported that nfxC-type mutants
express the MexE-MexF-OprN efflux system along with de-
creased OprD expression. Unfortunately, the position of the
50-kDa band cannot be used to distinguish between the three
outer membrane proteins (OprM, OprJ, or OprN) associated
with efflux systems of P. aeruginosa because of their similar
mobilities during sodium dodecyl sulfate-polyacrylamide gel
electrophoresis. It has been reported that MexE-MexF-OprN
increases resistance to chloramphenicol and trimethoprim but
not to tetracycline or cephalosporins (4). In order to evaluate
the possible activation of MexE-MexF-OprN by eluates, the
MICs of six antimicrobial agents (Table 1) against strains
HUS-3, PAO1, and OprD-deficient PAO1 were determined in
both MHB and eluate. The results showed in the table, how-
ever, are not conclusive. At this moment, it is not possible to
establish that the new 50-kDa protein is any of the known
outer membrane proteins associated with efflux systems or
even a totally different one. New experiments with P. aerugi-
nosa strains carrying mutations in the MexA-MexB-OprM,
MexC-MexD-OprJ, and MexE-MexF-OprN systems would
contribute to evaluation of their role, if any, in the resistance of
P. aeruginosa induced by SLUCs.
It is difficult to assess the relative importance of OprD de-
ficiency and of the 50-kDa protein expression induced by elu-
ate in the resistance of P. aeruginosa HUS-3. In the case of
IMP, it may be hypothesized that the loss of OprD is more
important than the expression of the 50-kDa protein, as MICs
of IMP against mutants MUT2 and OprD-deficient PAO1 are
the same in both MHB and eluate, although when both mu-
tants grow in eluate they also express the 50-kDa protein. Out-
er membrane protein changes and resistance to IMP reverted
when organisms grown in the presence of eluate were subse-
quently cultured in MHB, which indicates that eluate regu-
lates, by an unknown mechanism, the physiology of P. aerugi-
nosa rather than selects for rare mutants.
b-Lactamase activities in P. aeruginosa HUS-3 and MUT-2
grown in eluate (707 and 825 mU/mg of protein, respectively)
were similar to those observed after growing the organism in
MHB (809 and 832 mU/mg of protein, respectively). The high
level of enzyme produced by P. aeruginosa HUS-3 may con-
tribute to the observed resistance to IMP in the presence of
eluate. It is well known that the expression of chromosomal b-
lactamase in OprD-deficient strains determines resistance to
IMP in P. aeruginosa (6, 22).
The exact chemical nature of the materials used for
making SLUCs is not known. Preliminary chromatographic
characterization of the eluate resulted in the identification of
several major peaks, including N,N-dibutylformamide; 1,1,3-
FIG. 1. Outer membrane proteins of P. aeruginosa grown in MHB (lanes 1,
3, 5, and 6) or in eluate (lanes 2 and 4). Lanes: 1 and 2, strain HUS-3; 3 and 4,
mutant MUT2; 5, strain PAO1; 6, OprD-deficient mutant of PAO1. Molecular
markers are shown at right. The ca. 50-kDa new protein expressed in eluate is
marked with arrowheads.
TABLE 1. Susceptibility of P. aeruginosa strains to antimicrobial agents in MHB or MHB plus eluate from SLUCs
Strain
MIC (mg/ml)
Imipenem Ceftazidime Cefepime Cefpirome Trimethoprim Tetracycline Chloramphenicol
MHB Ea MHB E MHB E MHB E MHB E MHB E MHB E
HUS-3 1 16 32 32–64 8 32 64 128 128 256 16 16 128 256
PAO1 1 8–16 1 2 1 2 2 4 128 128 16 16 32 64
PAO1 OprD(2) 16 16 1 4 1 2 2 4 128 128 16 16 32 64
a E, MHB plus eluate from SLUCs.
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trimethyl-3-phenylindane; ethane-1,1-2-di-3,4-xylil; and phtha-
late derivatives. The activity of IMP against P. aeruginosa
HUS-3 remained unaltered in the presence of N,N-dimethyl-
formamide; dimethyl-phthalate; or diethyl-phthalate in con-
centrations ranging between 0.5 and 40 mg/ml (data not
shown). New experiments to evaluate the role of other SLUC
components as a cause of resistance of P. aeruginosa HUS-3 to
IMP are planned.
The clinical importance of these findings is unknown. As-
suming that the concentrations of substances eluted from
SLUCs could be high in the microenvironment of bacterial
biofilm, we may speculate that this is an advantageous situation
for P. aeruginosa attached to SLUCs because of its ability to
grow using the eluate as a nutrient and to evade the activity of
some antimicrobial agents.
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